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Multiple Sclerosis and Peripheral Multifocal Demyelinating 
Neuropathies Occurring in a Same Patient
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The  co-occurrence  of  multiple  sclerosis  and  peripheral  demyelinating  neuropathy  is  rare.  It  has  been  disputed 
whether  these  are  pathologically  related  or  coincidental  findings.  We  report  a  36-year-old  woman  who  presented 
with  diplopia,  right  facial  palsy  and  left-sided  weakness.  Brain  magnetic  resonance  imaging  showed  a  lesion 
indicative  of  central  demyelinating  disease.  Nerve  conduction  studies  revealed  peripheral  multifocal  demyelinating 
neuropathies.  We  suggest  that  the  central  and  the  peripheral  lesions  may  be  continua  of  a  demyelinating 
process.
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Co-occurrence of multiple sclerosis (MS) and peri-
pheral demyelinating neuropathy is rare, and there 
have been disputed whether these are pathogeneti-
cally related or coincidental findings.
1-8 We report a 
combination of MS and peripheral multifocal demyeli-
nating neuropathies in a Korean patient.
CASE REPORT
A 36-year-old woman presented in April, 2006 
with one week history of sustained headache in the 
right temporal area associated with numbness of the 
right face, hearing impairment, and vertigo. Ten years 
before, she underwent a thyroid gland operation due 
to hyperthyroidism and had been under thyroid hormone 
replacement therapy. Four months before the admission, 
she underwent a Caesarean section and had been 
breast-feeding. She had never experienced dry mouth, 
xerophthalmia, skin or oral ulcer, spontaneous abortion, 
or arthritis. Family history and other medical history 
were unrevealing. On admission, she complained of 
diplopia, but extraocular movement dysfunction or 
nystagmus were not observed. Muscle weakness of 
right face and palate were recorded, but dysphagia 
and dysarthria were not definite. Mild weakness of 
left extremities was recorded and deep tendon reflexes 
of left side were hypoactive. Pathologic reflexes or 
abnormality of muscular tone were not recorded. Her 
cerebellar function test was insignificant.
Her chest and cardiologic evaluation results were 
normal. Laboratory test such as complete blood cell 
count, erythrocyte sedimentation rate, and serologic 
tests including C-reactive protein, anti-GQ1b anti-
body, syphilis serology, human immunodeficiency 
virus antibody, rheumatoid factor, autoimmune markers 
such as antinuclear antibody, serum immunoglobulin 
did not show any abnormality. Her urine analysis did -A 1
-B 1
-C 1
Stimulation site Latency (ms) Amplitude (mV) NCV (m/s)
A1 Wrist 3.0 15.9
B1 Elbow 4.3 33.8
C1 Axilla 4.2 23.1
Figure 1. Demyelinating pattern with conduction block and temporal dispersion in motor conduction studies of left median 
nerve (2006.04.24, before the treatment).
Table 1. Serial nerve conduction studies (NCS)
(A)
2006.04.24 Right Left
Latency
(ms)
Amplitude NCV
(m/s) 
F-wave
(ms)
Latency
(ms)
Amplitude NCV 
(m/s)
F-wave
(ms)
Motor NCS (mV) (mV)
Median nerve   39.2↑ 42.8↑
APB-wrist  3.4 15.3  3.0 15.9
Wrist-elbow  9.8 14.3   34.5↓  9.5    4.3↓   33.8↓
Elbow-axilla 12.2 16.7   37.5↓ 13.4    4.2↓   23.1↓
Ulnar nerve   39.4↑ 41.6↑
ADM-wrist  2.1 17.9  2.0 16.8
Wrist-below elbow  6.9 10.2   44.8↓  6.8  9.7   45.8↓
Wrist-above elbow  8.6    5.4↓   38.2↓  8.9  9.4   33.3↓
Elbow-axllia 10.7    4.3↓   35.7↓ 11.8    6.2↓   20.7↓
Peroneal nerve 47.0 56.8↑
EDB-ankle  3.4  7.5  4.5  9.5
Ankle-fibular head 10.6  5.6 44.7 11.6  6.9 44.4
Tibial nerve   53.4↑ 54.4↑
AH-ankle  4.3 26.2  4.1 31.6
Ankle-knee 12.1 15.9 46.2 12.5 15.7 44.0
Sensory NCS (μV) (μV)
Median nerve
Finger-wrist 18.0 45.5 24.0 45.5
Wrist-elbow
Elbow-axilla
   3 . 4 ↓
29.4
54.3
54.1
   3 . 8 ↓
28.4
52.8
51.1
Ulnar nerve
Finger-wrist 11.0 39.6 15.6 43.8
Wrist-elbow
Elbow-axilla
  11.3↓
  10.9↓
49.2
46.9
   8 . 8 ↓
NP
54.9
NP
Sural nerve 17.1 40.7 22.0 45.3
NCV; nerve conduction velocity, APB; abductor pollicis brevis, ADM; abductor digiti minimi, EDB; extensor digitorum 
brevis, AH; abductor hallucis, NP; no potential.
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( B )                                                                                 (Continued from previous page)
2006.05.08 Right Left
Latency
(ms)
Amplitude NCV
 (m/s)
F-wave
(ms)
Latency
(ms)
Amplitude NCV
(m/s) 
F-wave
(ms)
Motor NCS (mV) (mV)
Median nerve    38.2↑   36.5↑
APB-wrist  3.0 15.0  3.3 14.8
Wrist-elbow 10.0  8.7    31.4↓ 10.4    2.8↓   31.7↓
Elbow-axilla 12.3  7.2    39.1↓ 13.2    2.6↓   28.6↓
Ulnar nerve    35.2↑   39.6↑
ADM-wrist  2.0 17.3  2.3 15.0
Wrist-below elbow  6.8 10.7    43.8↓  6.7  8.1   45.5↓
Wrist-above elbow  8.5    5.2↓    3 8 . 2 ↓  8.8    7.9↓   38.1↓
Elbow-axllia 10.3    4.1↓    4 1 . 7 ↓ 13.0    5.1↓   20.2↓
Peroneal nerve 41.6 43.8
EDB-ankle  3.5 10.6  4.5  8.5
Ankle-fibular head 10.7  8.4 45.8 11.0  6.7 47.7
Tibial nerve 44.6 44.5
AH-ankle  3.8 27.0  4.7 24.5
Ankle-knee 11.4 17.0 44.7 12.0 15.6 43.8
Sensory NCS (μV) (μV)
Median nerve
Finger-wrist 25.0 44.4 13.0 44.4
Wrist-elbow
Elbow-axilla
   7 . 2 ↓
30.0
55.9
57.1
   5 . 1 ↓
20.0
58.1
56.3
Ulnar nerve
Finger-wrist 15.0 39.1 13.0 39.1
Wrist-elbow
Elbow-axilla
  12.0↓
  11.0↓
52.8
46.3
   5 . 8 ↓
   5 . 0 ↓
52.6
47.5
Sural nerve 22.0 44.4 22.0 41.7
NCV; nerve conduction velocity, APB; abductor pollicis brevis, ADM; abductor digiti minimi, EDB; extensor digitorum 
brevis, AH; abductor hallucis, NP; no potential.
not show hematuria or proteinuria. Cerebrospinal fluid 
(CSF) analysis showed a protein level of 63 mg/dL, 
a glucose level of 65 mg/dL, and 3 cells/mm
3. An 
immunoglobulin G index (IgG index) was 0.564 and 
the CSF level of myelin basic protein (MBP) was 10 
ng/mL (normal level <1 ng/mL). An oligoclonal band 
of CSF was not demonstrated. The motor nerve con-
duction velocities of both median and ulnar nerves 
were markedly decreased and multiple conduction 
blocks were recorded on left median and both ulnar 
nerves (Fig. 1). The F wave latencies of both median, 
ulnar, tibial, and left peroneal nerves were prolonged 
and H-reflexes were not demonstrated bilaterally. 
These nerve conduction studies (NCS) were indicative 
of multifocal demyelinating neuropathies (Table 1-A). 
Pattern reversal visual-evoked potentials (VEP) and 
brainstem auditory-evoked potentials (BAEP) fell within 
normal ranges.
On hospital day 1, T2-weighted and fluid-attenuated 
inversion recovery magnetic resonance imaging (MRI) 
studies revealed an increased signal intensity in the 
right cerebellopontine angle with gadolinium-enhance-
ment (Fig. 2). This lesion showed high signal inten-
sity on diffusion MRI and apparent diffusion coeffi-
cient maps. She did not receive any treatment because 
her husband wanted her to be treated by oriental 
medicine. Five days later, she was admitted again 
because of left-sided numbness and ataxia with agg-
ravated dizziness. A follow-up MRI did not reveal 
any newly developed lesion. She was diagnosed as Journal of Clinical Neurology: Vol. 4, No. 1, 2008
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(B)
Figure 2. Brain MRI on first admission, (A) T2-weighted image showed a region of increased signal 
intensity in right cerebellopontine angle and (B) in gadolinium-enhanced image this lesion showed 
gadolinium-enhancement.
having multifocal demyelinating neuropathies and 
probable demyelinating disorder of central nervous 
system (CNS). Intravenous immunoglobulin (0.4 g/kg 
per day) was administered for 5 days. On the fourth 
day of immunoglobulin treatment, most of left sided- 
weakness and ataxia disappeared. After 15 days, the 
NCS showed decreased F-wave latencies of all tested 
nerves compared with those of previous study (Table 
1-B). For about 3 months after discharge, her gait 
disturbance and ataxia were resolved, but numbness 
of right extremities appeared transiently.
In August, 2006, she was admitted for the third 
time because of decreased visual acuity and color 
vision of right eye (0.2 OD; 1.0 OS). The swinging 
flashlight test showed the Marcus-Gunn pupillary 
sign on right eye. Other cranial nerves, motor, and 
sensory examinations were unrevealing. Reflexes of 
four extremities were hyperactive. On ophthalmoscopic 
examination, blurred margin of right optic disc was 
recorded. VEP showed prolonged P100 latency on 
right eye indicative of a prechiasmatic conduction 
defect of right visual pathway (Fig 3-A). Orbit MRI 
showed a gadolinium enhanced lesion on a pre-
chiasmatic area of right optic nerve and a region of (A) VEP at the time when visual 
symptoms of right eye happened
(B) After 8 months, follow-up VEP
Figure 3. Pattern-reversal visual evoked potentials test shows prolonged P100 latency of right eye.
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(A)                                                                (B)
Figure 4. Brain MRI on third admission, (A) T2-weighted image shows a region of high signal intensity on left lateral 
medulla, and (B) Fat-suppression image shows a gadolinium-enhanced lesion in a prechiasmatic area of right optic nerve. 
abnormally high signal intensity on left lateral medulla, 
which corresponded with right sided-numbness (Fig 
4). A follow-up CSF analysis showed a protein level 
of 59 mg/dL, a glucose level of 58 mg/dL, and 0 
cells/mm
3. An IgG index was 0.568 and MBP level 
was 2.2 ng/mL. An oligoclonal band of CSF was not 
demonstrated. Thus, she was diagnosed as having 
right optic neuritis and MS and intravenous high 
dose steroid pulse therapy (1000 mg/day) was done 
for 5 days, with gradual tapering with oral predni-
solone (1 mg/kg). Her visual acuity of right eye 
showed marked improvement in 2 weeks after steroid 
pulse therapy.
DISCUSSION
MS is a chronic disorder characterized by recurrent 
and relapsing lesions occurring in the brain, optic 
nerves, and the spinal cord.
9  The specific pathologic 
finding of MS is central demyelination which does 
not extend beyond the root entry zones of the cranial 
and spinal nerves.
9 As several cases of MS combined 
with peripheral demyelinating neuropathy have been 
reported, questions have been arising whether MS 
lesions should not extend beyond the root entry zones.
1-8 
Pollock et al. found demyelination of peripheral nerves 
in sural nerve biopsy of 10 patients with MS and 
suggested that the peripheral myelin might be involved 
in MS.
8 Furthermore, Mendell et al. detected white 
matter lesions indistinguishable from those seen in 
MS in 16 patients with inflammatory demyelinating 
polyradiculoneuropathy.
10
In our case, weakness and ataxia of left extremities, 
weakness and hypoesthesia of right face, and vertigo 
developed as initial manifestations which were followed 
by transient numbness of right extremities. Four months 
later, right optic neuritis suddenly developed. Thus, 
the series of manifestations appear to be compatible 
with temporal dissemination of demyelination process. 
Her serial brain MRI showed spatially disseminated 
demyelinating lesions. She was diagnosed as having 
MS on the basis of current diagnostic criteria.
11 On 
the first admission, her neurologic examination showed 
mild weakness and hyporeflexia of left extremities 
and the NCS revealed peripheral multifocal demye-
linating neuropathies without past history of peripheral 
nervous system lesion. Without pathological study, it 
is difficult to confirm whether the two disorders 
occurred coincidentally or occurred as different mani-
festations of the same demyelinating process. MS is 
rare in Korea as compared to western countries. De-
myelinating neuropathy is also an uncommon disorder. 
The clinical course of the patient as well as the co- 
occurrence of two rare diseases suggest that the 
central and the peripheral demyelination might be  
different manifestations of a broad spectrum of the 
same immunopathologic dysfunction.Kwon JY, et al. Multiple Sclerosis and Peripheral Demyelinating Neuropathies Occurring in a Patient
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